Biohaven Ltd (NYSE: BHVN): A Suicide Machine Or A Millionaire’s Dream?

In the last trading session, 0.65 million shares of the Biohaven Ltd (NYSE:BHVN) were traded, and its beta was 3.99. Most recently the company’s share price was $30.45, and it changed around -$1.61 or -5.02% from the last close, which brings the market valuation of the company to $3.08B. BHVN currently trades at a discount to its 52-week high of $62.21, offering almost -104.3% off that amount. The share price’s 52-week low was $26.80, which indicates that the current value has risen by an impressive 11.99% since then.

Biohaven Ltd stock received a consensus recommendation rating of Buy, based on a mean score of 1.13. If we narrow it down even further, the data shows that 0 out of 16 analysts rate the stock as a Sell; another 5 rate it as Overweight. Among the rest, 0 recommended BHVN as a Hold, whereas 11 deemed it a Buy, and 0 rated it as Underweight. Biohaven Ltd is expected to report earnings per share of -1.75 for the current quarter.

Biohaven Ltd (NYSE:BHVN) trade information

Instantly BHVN has showed a red trend with a performance of -5.02% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 38.23 on recent trading dayincreased the stock’s daily price by 20.35%. The company’s shares are currently down -18.47% year-to-date, but still down -16.42% over the last five days. On the other hand, Biohaven Ltd (NYSE:BHVN) is -20.39% down in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $60, which translates to bulls needing to increase their stock price by 49.25% from its current value. Analyst projections state that BHVN is forecast to be at a low of $57 and a high of $65.

Biohaven Ltd (BHVN) estimates and forecasts

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -49.78%. Biohaven Ltd earnings are expected to increase by 27.61% in 2025, but the outlook is positive 24.96% per year for the next five years.

Biohaven Ltd (NYSE:BHVN)’s Major holders

BLACKROCK INC., with 7.5608% or 6.17 million shares worth $214.15 million as of 2024-06-30, holds the second largest percentage of outstanding shares.

Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF were the top two Mutual Funds as of Sep 30, 2024. The former held 2.43 shares worth $74.91 million, making up 2.40% of all outstanding shares. On the other hand, iShares Russell 2000 ETF held roughly 2.31 shares worth around $71.29 million, which represents about 2.29% of the total shares outstanding.